Development of Novel Small Molecules as Potential Anti-Cancer Agents

Rowan University

Project Details

StatusFinished
Effective start/end date1/1/15 → 6/30/23

Funding

  • Channel Therapeutics Inc.: $158,141.76
  • Channel Therapeutics Inc.: $62,479.00